DE3789859D1 - Formen des Koloniestimulierungsfaktors 1. - Google Patents

Formen des Koloniestimulierungsfaktors 1.

Info

Publication number
DE3789859D1
DE3789859D1 DE3789859T DE3789859T DE3789859D1 DE 3789859 D1 DE3789859 D1 DE 3789859D1 DE 3789859 T DE3789859 T DE 3789859T DE 3789859 T DE3789859 T DE 3789859T DE 3789859 D1 DE3789859 D1 DE 3789859D1
Authority
DE
Germany
Prior art keywords
forms
stimulation factor
colony stimulation
csf
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3789859T
Other languages
English (en)
Other versions
DE3789859T2 (de
Inventor
Kirston Edward Koths
Robert Forgan Halenbeck
Ernest Seigo Kawasaki
Martha Ballie Ladner
Mazie Yee Coyne
Arsdell Janelle Nobel Van
George Arthur Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp filed Critical Cetus Oncology Corp
Application granted granted Critical
Publication of DE3789859D1 publication Critical patent/DE3789859D1/de
Publication of DE3789859T2 publication Critical patent/DE3789859T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Luminescent Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal Substances (AREA)
DE3789859T 1986-10-24 1987-10-23 Formen des Koloniestimulierungsfaktors 1. Expired - Fee Related DE3789859T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92306786A 1986-10-24 1986-10-24
US3965487A 1987-04-16 1987-04-16
US3965787A 1987-04-16 1987-04-16

Publications (2)

Publication Number Publication Date
DE3789859D1 true DE3789859D1 (de) 1994-06-23
DE3789859T2 DE3789859T2 (de) 1994-09-15

Family

ID=27365583

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3789859T Expired - Fee Related DE3789859T2 (de) 1986-10-24 1987-10-23 Formen des Koloniestimulierungsfaktors 1.

Country Status (12)

Country Link
EP (1) EP0272779B1 (de)
JP (1) JP2644794B2 (de)
AT (1) ATE105869T1 (de)
AU (2) AU8007087A (de)
CA (1) CA1339032C (de)
DE (1) DE3789859T2 (de)
DK (1) DK174237B1 (de)
ES (1) ES2052580T3 (de)
FI (1) FI102190B1 (de)
HU (1) HU215241B (de)
NO (1) NO301775B1 (de)
WO (1) WO1988003173A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573930A (en) 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
US6117422A (en) * 1985-02-05 2000-09-12 Chiron Corporation N∇2-CSF-1(long form) and carboxy truncated fragments thereof
US5422105A (en) * 1985-02-05 1995-06-06 Cetus Oncology Corporation Use of recombinant colony stimulating factor 1
US5104650A (en) * 1985-02-05 1992-04-14 Cetus Corporation Uses of recombinant colony stimulating factor-1
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
US5837229A (en) * 1985-02-05 1998-11-17 Chiron Corporation Uses of recombinant colony stimulating factor-1
AU595864B2 (en) * 1986-03-14 1990-04-12 Otsuka Pharmaceutical Co., Ltd. Il-1 alpha derivatives and drugs
WO1987006954A1 (en) * 1986-05-06 1987-11-19 Genetics Institute, Inc. Production of m-csf
JP2583829B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 ヒトｍ−ｃｓｆ
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
US5650297A (en) * 1986-09-17 1997-07-22 Otsuka Pharmaceutical Co., Ltd. DNA encoding human colony-stimulating factors
EP0276551B1 (de) * 1986-12-07 1992-03-18 Morinaga Milk Industry Co., Ltd. Kolonie-stimulierender Faktor und Verfahren zu seiner Herstellung
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
AU2251488A (en) * 1987-07-24 1989-03-01 Cetus Corporation Production of biologically active forms of csf using a baculovirus (acnpv)-insect cell expression system
DK54589A (da) * 1988-02-08 1989-08-09 Otsuka Pharma Co Ltd Humane kolonistmulerende faktorer
JPH0610137B2 (ja) * 1988-02-29 1994-02-09 新技術事業団 ヒト単球−マクロファージコロニー刺激因子を有効成分とする造血器疾患治療剤
US5171675A (en) * 1988-07-28 1992-12-15 Cerretti Douglas P Macrophage colony stimulating factor-γ
WO1990012877A1 (en) * 1989-04-19 1990-11-01 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
EP0410751B1 (de) * 1989-07-27 1996-04-10 Denki Kagaku Kogyo Kabushiki Kaisha Für M-CSF kodierendes Gen und dazu gehörende rekombinante Systeme
KR920701253A (ko) * 1989-11-07 1992-08-11 오오쓰까 아끼히꼬 M-csf 유도체, 그 유도체의 발현 벡터, 그 벡터를 갖는 형질 전환체 및 이들의 제조방법
US5714140A (en) * 1989-12-13 1998-02-03 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting the production of bioactive IL-1 by administering M-CSF
DE4014750A1 (de) * 1990-05-08 1991-11-14 Boehringer Mannheim Gmbh Muteine des granulozyten-stimulierenden faktors (g-csf)
AU639091B2 (en) * 1991-04-24 1993-07-15 Otsuka Pharmaceutical Co., Ltd. M-csf derivatives, expression vectors for said derivatives, transformants carrying said vectors and production of these
DE69329247T2 (de) 1992-06-09 2001-05-31 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Kristallisierung von m-csf
AU6125294A (en) * 1993-01-13 1994-08-15 Genetics Institute Inc. Process for producing m-csf 223
GB2355791B (en) 1999-10-28 2004-10-20 Molecular Light Tech Res Ltd Detection of mRNA expression using chemiluminescent labelled probes
KR100371264B1 (ko) * 2000-01-25 2003-02-05 양문식 무라인 그래뉼로사이트-매크로파지 콜로니 자극 인자를포함하는 재조합 벡터와 그것을 발현하는 재조합아스퍼질러스 나이거
DK3417701T3 (da) 2009-10-06 2022-03-14 Regeneron Pharma Genmodificerede mus og indpodning
EP4233537A3 (de) * 2011-02-15 2023-09-13 Regeneron Pharmaceuticals, Inc. Humanisierte m-csf-mäuse und deren verwendungen
JP6283031B2 (ja) 2012-09-07 2018-02-21 イエール ユニバーシティ 遺伝学的に修飾された非ヒト動物およびその使用法
RU2673156C2 (ru) 2012-11-05 2018-11-22 Ридженерон Фармасьютикалз, Инк. Генетически модифицированные не относящиеся к человеческому роду животные и способы их применения
AU2015264427B2 (en) 2014-05-19 2021-09-23 Institute For Research In Biomedicine (Irb) Genetically modified non-human animals expressing human EPO
DK3282835T3 (da) 2015-04-13 2023-06-26 Regeneron Pharma Humaniserede SIRP?-IL-15-knockin-mus og fremgangsmåder til anvendelse deraf

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004607A1 (en) * 1985-02-05 1986-08-14 Cetus Corporation Recombinant colony stimulating factor-1
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子

Also Published As

Publication number Publication date
HUT47635A (en) 1989-03-28
DE3789859T2 (de) 1994-09-15
AU8149491A (en) 1991-10-31
AU646277B2 (en) 1994-02-17
CA1339032C (en) 1997-04-01
DK350188D0 (da) 1988-06-24
HU215241B (hu) 1998-11-30
AU8007087A (en) 1988-04-28
NO882772L (no) 1988-08-22
WO1988003173A2 (en) 1988-05-05
FI102190B (fi) 1998-10-30
ES2052580T3 (es) 1994-07-16
DK174237B1 (da) 2002-10-07
DK350188A (da) 1988-08-19
FI883056A0 (fi) 1988-06-23
EP0272779A2 (de) 1988-06-29
FI883056A (fi) 1988-06-23
WO1988003173A3 (en) 1988-07-28
NO301775B1 (no) 1997-12-08
NO882772D0 (no) 1988-06-22
FI102190B1 (fi) 1998-10-30
EP0272779A3 (en) 1988-08-03
ATE105869T1 (de) 1994-06-15
EP0272779B1 (de) 1994-05-18
JP2644794B2 (ja) 1997-08-25
JPH01501283A (ja) 1989-05-11

Similar Documents

Publication Publication Date Title
ATE105869T1 (de) Formen des koloniestimulierungsfaktors 1.
FI864016A (fi) Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1.
ATE358176T1 (de) Menschliche dnase
ATE124959T1 (de) Herstellung und verwendung von nicht- glycosiliertem il-6.
DK0433827T3 (da) Cytotoksisk lumfocytmodningsfaktor
NO164177C (no) Rekombinant dna-fremgangsmaate for fremstilling av et polypeptid med funksjon av human immun (gamma)-interferon.
FI873141A (fi) Daeggdjurs interleukin-4.
ATE147099T1 (de) Menschliches gp130-protein codierende dns
PT83813A (de) Eukaryotische fusionsproteine ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
DE3750113D1 (de) Für menschliche "Colony-stimulating"-Faktoren kodierendes Gen.
ATE107362T1 (de) Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
NO177863C (no) Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer
NO863918D0 (no) Leukopenia-behandlingsmiddel og fremgangsmaate for dets fremstilling.
DE3852870D1 (de) Saurer Fibroblast-Wachstumsfaktor-Mutant.
ES8703928A1 (es) Un metodo para preparar la proteina factor de estimulacion de colonias (csf-1)recombinante

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CHIRON CORP. (N.D.GES.D. STAATES DELAWARE), EMERYV

8339 Ceased/non-payment of the annual fee